Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.13, $0.04 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $134.5 million versus the consensus estimate of $160.5 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.